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Aging is the sum of the deleterious changes that occur as time goes by. It is the main risk factor for the
development of cardiovascular disease, and aging of the vasculature is the event that most often impacts on the
health of elderly people. The “free-radical theory of aging” was proposed to explain aging as a consequence of the
accumulation of reactive oxygen species (ROS). However, recent findings contradict this theory, and it now seems
that mechanisms mediating longevity act through induction of oxidative stress. In fact, calorie restriction − a
powerful way of delaying aging − increases ROS accumulation due to stimulation of the basal metabolic rate;
moreover, reports show that antioxidant therapy is detrimental to healthy aging. We also now know that genetic
manipulation of the insulin-like-growth-factor-1/insulin signal (IIS) has a profound impact on the rate of aging and
that the IIS is modulated by calorie restriction and physical exercise. The IIS regulates activation of nitric oxide
synthase (eNOS), the activity of which is essential to improving lifespan through calorie restriction, as demonstrated
by experiments on eNOS knockout mice. Indeed, eNOS has a key role in maintaining vascular integrity during aging
by activating vasorelaxation and allowing migration and angiogenesis. In this review, we will overview current
literature on these topics and we will try to convince the reader of the importance of vascular integrity and nitric
oxide production in determining healthy aging.
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Max Rubner’s “rate of living” theory [1] combined mass-
specific resting metabolic rate and maximum lifespan of
mammalian species to calculate the “lifetime energy po-
tential”: it holds that the pace of life is inversely related to
the length of life. Raymond Pearl [2] used this concept to
explain longevity variation within species and gave it the
“rate of living” label.
The subsequent “free-radical theory of aging” (FRTA)
was formulated from the above concepts: Harman [3]
postulated that accumulation of free radicals was the
prime cause of the sequential alterations characterizing
advancing age and the progressive increase in disease
and death rates [4].
With the introduction of a “lipids” perspective to the
FRTA, it was then asserted that the level of peroxidizabil-
ity of the cell membrane bilayer was a critical determinant* Correspondence: cvecchione@unisa.it
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reproduction in any medium, provided the orof the severity of cell damage caused by free radicals: in
response to attack by free radicals, peroxidation − the
susceptibility to which is dictated by the number of
single-bonded carbon atoms between the –C=C– units
of the fatty acyl chain − generates a strong self-propagating
reaction that causes damage to other molecules [5].
The “membrane pacemaker” theory of aging incorpo-
rates these concepts to hold that high membrane fluidity
and low membrane peroxidizability are the optimal
membrane conditions for promoting longevity. This the-
ory arose from the observation that body mass/max-
imum lifespan in mammals and birds correlates
respectively directly and inversely with the levels of
C18:1n-9 and C22:6n-3 fatty acids in cellular mem-
branes. This can be explained by the fact that C22:6n-3
is 320-fold more susceptible than C18:1n-9 to peroxida-
tion, while the latter fatty acid has fluidity properties as
good as the former [6].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Exceptional longevity in humans is a complex trait.
Long-living individuals have delayed aging and a low in-
cidence of cardiovascular disease [7,8]. We recently
reported that in children of nonagenarians the peroxida-
tion index of erythrocyte membrane lipids was signifi-
cantly lower than in a group of matched controls [9]. It is
of particular interest that we found significantly increased
levels of palmitoleic acid (C16:1n-7) in the nonagenarians’
offspring, similarly to what was later observed in genetic-
ally modified long-living worms [10]. Because these
worms were genetically modified in homologue genes of
the insulin-like growth factor 1 (IGF1)/forkhead box O3
(FOXO3A) axis, a possible explanation for this finding is
that IGF-1 signalling modulates, or is modulated by, the
membrane fatty-acid composition [11]. Moreover, it was
reported that after chronic thermal or saline stress of
yeast, the induced increase in the level of membrane pal-
mitoleic acid was responsible for a reset of heat shock pro-
tein (Hsp) release to higher levels [12]. Thus, the high
C16:1n-7 detected in the offspring of nonagenarians could
be correlated to the low serum level of Hsp70 detected in
centenarians’ offspring [13].
In apparent contrast with the FRTA is the finding that
the cell membranes of offspring of nonagenarians as well
as of long-living DAF2 Caenorhabditis elegans mutants
have an accumulated amount of endogenous trans fatty
acids [9 and unpublished data]. Endogenous trans fatty
acids are an index of endogenous free-radical cellular
stress and are produced by endothelial nitric oxide syn-
thase (eNOS)-generated nitrates (NO2·), as shown by the
lack of trans-arachidonic acids in the retinas of eNOS−/−
mice [14]. Moreover, calorie restriction has been shown
to increase longevity in organisms ranging from yeasts
to mammals; it induces the expression of eNOS and
mitochondrial biogenesis, which in turn increases
oxygen consumption. These effects were abolished in
eNOS−/− mice [15]. We therefore speculated that eNOS,
nitrate radical stress and the trans fatty-acid accumula-
tion observed in nonagenarians’ offspring are all inter-
connected in the delayed-aging action of calorie
restriction, in apparent contrast with the FRTA [16]. The
trans fatty acids could serve as molecular signals that ul-
timately induce endogenous defence mechanisms cul-
minating in increased stress resistance and longevity, an
adaptive response named hormesis [17].
In agreement with this hypothesis, deletion in worms
of mitochondrial proteins such as ISP-1 and NUO-6
induces the oxidative stress necessary and sufficient for
promoting longevity: in fact, this effect is abolished by
antioxidants and is induced by mild treatment with
oxidants [18]. Taken together, these findings question
Harman's FRTA and suggest, rather, that reactive oxy-
gen species (ROS) act as essential signalling moleculespromoting metabolic health and longevity through an
eNOS/nitrate/trans fatty acids axis [19]. The degree of
oxidative stress could possibly explain this apparent
paradox: low stress being protective, whereas massive
stress becomes deleterious.
Calorie restriction, exercise, genetic makeup and eNOS
The beneficial effects of calorie restriction are multiple:
it reduces the incidence of tumours and diabetes and the
age-related decline in T-lymphocyte proliferation [20].
The effects of calorie restriction can be explained by
increased IGF1-insulin signal (IIS) efficiency: in fact,
findings on patients with growth hormone receptor defi-
ciency suggest that their high insulin sensitivity could
account for the absence of diabetes and very low inci-
dence of cancer seen in these individuals [21].
Furthermore, calorie restriction can be mimicked by
genetic manipulation aimed at blocking IIS (i.e., the
IGF1/PI3K/AKT/FOXO3A axis): for example, the FIRKO
mouse − a carrier of a fat-specific insulin receptor knock-
out − and C. elegans models carrying null mutations of
daf-2 − an IGF1 homologue − and age-1 − a homologue
of the catalytic subunit of mammalian PI3K− all live
longer than wild-type animals [22,23]. To be noted, the
beneficial effects of daf-2 and age-1 null mutations are
antagonized by null mutation of daf-16, which encodes
three members of the FOXO family of transcription
factors [23]. Thus, via AKT the IIS is important for con-
trolling eNOS and, hence, human longevity [24].
Genetic variants that are either protective or deleterious
for human health can be identified by studying the genetic
pool of centenarians: the so called “positive biology ap-
proach” [25,26]. Interestingly, apolipoprotein E (APOE) − a
variant of which is associated with exceptional longevity in
humans across populations − controls the IIS pathway by
influencing PI3K [27]. Similarly, the presence of genetic
variants of FOXO3A − another member of the IIS − is
highly replicable in long-living populations [28-30].
Exercise is inversely correlated with total mortality
[31]. An elegant report on athletes undergoing marathon
training identified a combination of metabolites (i.e., glyc-
erol, niacinamide, glucose-6-phosphate, pantothenate
and succinate) that increased in the plasma in re-
sponse to exercise; in vitro, these metabolites were
able to up-regulate the expression of NUR77, a tran-
scriptional regulator of glucose utilization and lipid
metabolism genes [32]. NUR77 is under the control of
Ca2+/calmodulin-dependent protein kinase (CAMKIV),
which is activated by AMPK and has been associated
with human exceptional longevity [33,34]. Furthermore,
AMPK controls eNOS phosphorylation, which explains
the potentiation of eNOS activity by both calorie re-
striction and physical exercise [24]. AMPK is activated
acutely at exercise intensities above ≈ 60% of maximal
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both activate mitochondrial biogenesis through activa-
tion of AMPK with an eNOS-dependent mechanism,
as shown by experiments on eNOS knockout mice
[36]. Thus, the beneficial effects on longevity of calorie re-
striction, genetic makeup and exercise can be explained,
at least in part, through eNOS-dependent activation of
mitochondrial biogenesis.
Vascular endothelial dysfunction and eNOS in aging
Endothelial dysfunction is the hallmark of vascular
damage in advancing age [37-41]. Many functions of
the vascular endothelium are modulated by NO, which
is able to induce smooth muscle relaxation [42-44], theFigure 1 a) Representative nitric oxide pathway. b) Effects of aging o
ion; cGMP = cyclic guanosine monophosphate; eNOS = endothelial nitric o
adenine dinucleotide phosphate; NO = nitric oxide; ONOO- = Peroxynitriteinhibition of platelet aggregation [45], leukocyte adhe-
sion to endothelial cells [46,47] and preservation of
endothelial progenitor cell function [48] (Figure 1a).
The crucial role of NO in protecting the cardiovascular
system during aging was revealed by studies demon-
strating that eNOS knockout mice have a premature
cardiac-aging phenotype and early mortality [49].
Reduction of NO availability alters vascular homeosta-
sis [50] and is a phenomenon involved in the de-
velopment of hypertension [50,51], atherosclerosis and
thrombosis leading to heart attack and stroke [52-54].
The mechanisms underlying vascular aging are complex
and involve multiple pathways [41,55,56] (Figure 1b).
During aging, there is a progressive misbalance betweenn nitric oxide pathway. BH4 = tetrahydrobiopterin; Ca
2+ = calcium
xide synthase; GTP = guanosine triphosphate; NADPH = nicotinamide
; ADMA = Dimethylarginine; ROS = reactive oxygen species.
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and oxidative stress − which increases without a com-
pensatory enhancement of antioxidant defences [57-59].
As a result, aged vessels have a compromised vasodilatory
function, which induces increased vascular resistance and
impaired perfusion [60]. Reduced NO production may
be dependent upon several mechanisms, including:
a) deficiency in eNOS substrates and cofactors, such
as l-arginine [61] and tetrahydrobiopterin (BH4) [62]; b)
the presence of endogenous eNOS inhibitors, such as
asymmetric dimethylarginine (ADMA) [63,64] and analo-
gues of l-arginine present in plasma and various tissues,
which have been described as cardiovascular risk factors
[65]; and c) lower expression and/or activity of eNOS due
to abnormalities in eNOS trafficking to caveolae, to
altered eNOS phosphorylation status or to uncoupling of
eNOS activity [39,66,67].
An important molecule regulating eNOS activity is sir-
tuin 1 (Sirt-1), a longevity factor that modulates cellular
senescence [68] and promotes endothelium-dependent
vasodilation by targeting eNOS for deacetylation [69].
Sirt-1 expression was found lower in endothelial cells
from older adults than healthy younger individuals
[66,70] in which endothelial vasorelaxation was demon-
strated to be positively related to Sirt-1 expression.
Calorie restriction − which improves health and slows
the aging process − has been reported to induce eNOS
expression, improve mitochondrial biogenesis and in-
crease Sirt-1 expression; thus, a positive feedback loop
links Sirt-1 and eNOS [71], and activation of SIRT1 may
help to reset the activity of eNOS during situations of
endothelial dysfunction where NO availability is limited.
BH4 is an essential cofactor for NO synthesis by
eNOS. When it is limited − because of a decrease in bio-
synthesis or an increase in its oxidation − eNOS
becomes uncoupled and induces release of superoxide,
which, in turn, leads to degradation of NO. Administra-
tion of BH4 to older adults caused a selective improve-
ment in endothelial vasorelaxation, demonstrating that
BH4 potentially leads to eNOS recoupling in aged
human vasculature [72].
Another mechanism that reduces NO bioavailability,
hence contributing to vascular endothelial dysfunction with
aging, is oxidative stress [73]. Oxidative stress is induced
mainly by uncoupling of eNOS, upregulation of the oxidant
enzyme nicotinamide adenine dinucleotide phosphate-
oxidase (NADPH oxidase) [50,74,75] or increased mito-
chondrial production of ROS [76-79]. Increased expression
of NADPH oxidase has been reported in vessels from aged
humans not presenting with other cardiovascular risk
factors. The use of NADPH inhibitors protects from age-
related endothelial dysfunction [80].
Finally, a reduction in the number of mitochondria
and an increase in the generation of dysfunctionalproteins have been linked to aging through increased
oxidative stress and mitochondrial DNA damage [81].
The mechanisms of mitochondrial oxidative stress in
aged endothelial cells include also inhibition of antioxi-
dant defence enzymes, such as manganese superoxide
dismutase (MnSOD) [82], decline in reduced glutathione
content [83] and dysfunction of the electron transport
chain [84]. The mitochondrial enzyme p66shc seems to
play an important role in regulation of oxidative stress
induction, since mice lacking p66hc present with
reduced ROS production, improved endothelial function
and increased lifespan [85]. However, conflicting findings
exist on the effects of antioxidants on vascular function
in elderly humans. For example, a study on vitamin E
reported that its administration does not reduce endo-
thelial dysfunction in older adults [86]. In contrast, a
more recent clinical trial demonstrated acute reversal of
endothelial dysfunction in elderly patients after oral
administration of an antioxidant cocktail [87].Conclusions
The NO pathway and endothelial dysfunction are part of
the principal mechanisms involved in the vascular aging
process. A better understanding of the complex interac-
tions between them represents an important target for fu-
ture research. Therapeutic strategies designed to improve
endothelial function or provide an alternative source of
NO should be primary aims in the drive to reduce the in-
cidence of cardiovascular disease in the elderly. Moreover,
studies need to better investigate the effects of antioxidant
therapy on endothelial dysfunction in aging.Abbreviations
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